Search NASA⌕ Search

SEARCH · Search NASA

Results for “molecular orbitals”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 523 records · Page 29
All sourcesNASA NTRSDOE OSTI
NASA NTRS2002

Dynamical Studies of the Middle Atmosphere Using High Resolution Doppler Imager Observations

This report summarizes the activities of NASA grant NAG5-11068, "Dynamicai Studies of the Middle Atmosphere Using High Resolution Doppler Imager Observations." The High Resolution Doppler Imager (HRDI) on the Upper Atmosphere Research Satellite (UARS) has been providing direct measurements of the Earth's horizontal wind field in the stratosphere, mesosphere and lower thermosphere. Mesospheric temperatures, ozone, and O((sup 1) D) densities, and stratospheric aerosol extinctions coefficients, are also retrieved. The goal of HRDI is to measure the vector winds in the stratosphere (10-40 km), mesosphere, and lower thermosphere (approximately 50-120 km) during the day, and the lower thermosphere at night (approximately 95 km) to an accuracy of 5 m/s. The horizontal wind vector is measured by observing the Doppler shift of rotational lines of molecular oxygen along two lines of sight. In addition to winds, temperatures and volume emission rates are determined in the mesosphere and lower thermosphere, from which ozone and O((sup 1) D) concentrations can be derived, and aerosol scattering coefficients are determined in the stratosphere. UARS was launched on September 12, 1991, into a 585-km circular orbit inclined 57 degrees to the equator HRDI was activated September 28, 1991 and following a period of checkout and adjustment of the instrument parameters, scientific observations began November 2, 199 1. HRDI operated nearly continuously from launch until April 1995. At that time the UARS solar array drive failed, forcing the instruments to time-share the available power. From July 1995 to July 1996 HRDI operated approximately 50% of the time. At that point, one of the three spacecraft batteries failed and from then until September 1998 the duty cycle was less than 20% per month, At that time it was determined that HRDI could operate during each daytime pass, which increased the daytime duty cycle to close to l00%, while nighttime operations were limited to about a week per month. In the fall of 1999, the second tape recorder failed requiring a real time contact with a TRDSS satellite to retrieve that data. This resulted in about 60% data collection efficiency. Finally, in the summer of 2000, the second star sensor failed requiring the spacecraft attitude to be controlled by a three axis magnetometer and sun sensor. This resulted in a loss of attitude knowledge but operations continue with the anticipation of correcting the attitude. A new method for determining the tide and mean structure from satellite data in conjunction with a new tidal model has been devised. For brevity, it shall be referred to as the TMAT or Tide-Mean Assimilation Technique. Most previous methods of tidal analysis are based on various ways of slicing the data set.

Skinner, Wilbert↗
NASA NTRS2006

Decoding IR Spectra of Cosmic Ices and Organics in the Laboratory

Tremendous strides have been made in our understanding of interstellar material over the past twenty-five years thanks to significant developments in observational IR astronomy and dedicated laboratory experiments. Twenty-five years ago the composition of interstellar dust was largely guessed at. Today the composition of interstellar dust is reasonably well understood. In the diffuse interstellar medium (ISM) the dust population is mainly comprised of small grains of silicates and amorphous carbon. In dark molecular clouds, the birthplace of stars and planets, these cold refractory dust particles are coated with mixed molecular ices whose composition is reasonably well constrained. Lastly, the signature of carbon-rich polycyclic aromatic hydrocarbons (PAHs), shockingly large molecules by early interstellar chemistry standards, is widespread throughout the Universe. This extraordinary progress has been made possible by the close collaboration of laboratory experimentalists and theoreticians with IR astronomers using groundbased, air-borne, and orbiting telescopes.

Allamandola, Louis J.↗
NASA NTRS2011

MIRO Observation of Comet C/2002 T7 (LINEAR) Water Line Spectrum

Comet C/2002 T7 (LINEAR) was observed with the Microwave Instrument for Rosetta Orbiter (MIRO) on April 30, 2004, between 5 hr and 16 hr UT. The comet was 0.63AU distance from the Sun and 0.68AU distance from the MIRO telescope at the time of the observations. The water line involving the two lowest rotational levels at 556.936 GHz is observed at 557.070 GHz due to a large Doppler frequency shift. The detected water line spectrum is interpreted using a non local thermal equilibrium (Non-LTE) molecular excitation and radiative transfer model. Several synthetic spectra are calculated with various coma profiles that are plausible for the comet at the time of observations. The coma profile is modeled with three characteristic parameters: outgassing rate, a constant expansion velocity, and a constant gas temperature. The model calculation result shows that for the distant line observation where contributions from a large coma space is averaged, the combination of the outgassing rate and the gas expansion velocity determines the line shape while the gas temperature has a negligible effect. The comparison between the calculated spectra and the MIRO measured spectrum suggests that the outgassing rate of the comet is about 2.0x1029 molecules/second and its gas expansion velocity about 1.2 km/s at the time of the observations.

spectral line↗
NASA NTRS1985

Space shuttle molecular and wake vacuum measurements

The wake environment of the space shuttle is analyzed to determine whether it is feasible to perform ultrahigh vacuum experiments in or near the payload bay with the shuttle oriented such that the payload bay faces the antivelocity direction. Several mechanisms were considered by which molecules could approach the payload bay from this direction and their relative contributions to the wake environment are estimated. These mechanisms include ambient atmospheric molecules that have velocities in excess of the orbital velocity which can overtake the shuttle, ambient atmospheric molecules that are backscattered by collisions with the shuttle induced atmosphere, and self scattering from the induced atmosphere. These estimates are compared with the measurements made with the collimated mass spectrometer which was part of the Induced Environment Contamination Monitor flown on several of the early shuttle flights. Although the collimated mass spectrometer was not designed for this purpose and the instrument background for the species for which the collimator is effective is above the expected levels, upper limits can be established for these species in the wake environment which are consistent with the analysis. There was considerably more helium and argon observed in the wake direction than was predicted, however. Possible origins of these gases are discussed.

Naumann, R. J.↗
NASA NTRS2001

MIR Solar Array Return Experiment: Power Performance Measurements and Molecular Contamination Analysis Results

A solar array segment was recently removed from the Mir core module and returned for ground-based analysis. The segment, which is similar to the ones the Russians have provided for the FGB and Service Modules, was microscopically examined and disassembled by US and Russian science teams. Laboratory analyses have shown the segment to he heavily contaminated by an organic silicone coating, which was converted to an organic silicate film by reactions with atomic oxygen within the. orbital flight environment. The source of the contaminant was a silicone polymer used by the Russians as an adhesive and bonding agent during segment construction. During its life cycle, the array experienced a reduction in power performance from approx. 12%, when it was new and first deployed, to approx. 5%, when it was taken out of service. However, current-voltage measurements of three contaminated cells and three pristine, Russian standard cells have shown that very little degradation in solar array performance was due to the silicate contaminants on the solar cell surfaces. The primary sources of performance degradation is attributed to "thermal hot-spotting" or electrical arcing; orbital debris and micrometeoroid impacts; and possibly to the degradation of the solar cells and interconnects caused by radiation damage from high energy protons and electrons.

Visentine, James↗
NASA NTRS1996

DSMC Grid Methodologies for Computing Low-Density, Hypersonic Flows About Reusable Launch Vehicles

Two different grid methodologies are studied for application to DSMC simulations about reusable launch vehicles. One method uses an unstructured, tetrahedral grid while the other uses a structured, variable-resolution Cartesian grid. The relative merits of each method are discussed in terms of accuracy, computational efficiency, and overall ease of use. Both methods are applied to the computation of a low-density, hypersonic flow about a winged single-stage-to-orbit reusable launch vehicle concept at conditions corresponding to an altitude of 120 km. Both methods are shown to give comparable results for both surface and flowfield quantities as well as for the overall aerodynamic behavior. For the conditions simulated, the flowfield about the vehicle is very rarefied but the DSMC simulations show significant departure from free-molecular predictions for the surface friction and heat transfer as well as certain aerodynamic quantities.

Wilmoth, Richard G.↗
NASA NTRS2011

HST/WFC3 Observations of Giant Hot Exoplanets

Low resolution thermal emission spectra of several dozen extrasolar planets have been measured using Spitzer, and HST observations of a few key exoplanets have reported molecular abundances via transmission spectroscopy. However, current models for the atmospheric structure of these worlds exhibit degeneracies wherein different combinations of temperature and molecular abundance profiles can fit the same Spitzer data. The advent of the IR capability on HST/WFC3 allows us to address this problem. We are currently obtaining transmission spectroscopy of the 1.4-micron water band in a sample of 13 planets, using the G141 grism on WFC3. This is the largest pure-exoplanet program ever executed on HST (115 orbits). Among the abundant molecules, only water absorbs significantly at 1.4-microns, and our measurement of water abundance will enable us to break the degeneracies in the Spitzer results with minimal model assumptions. We are also using the G141 grism to observe secondary eclipses for 7 very hot giant exoplanets at 1.S-microns, including several bright systems in the Kepler and CoRoT fields. The strong temperature sensitivity of the thermal continuum at 1.S-microns provides high leverage on atmospheric temperature for these worlds, again helping to break degeneracies in interpreting the Spitzer data. We here describe preliminary results for several exoplanets observed in this program.

Deming, D.↗
NASA NTRS2016

Metallic Hydrogen: A Game Changing Rocket Propellant

The objective of this research is to produce metallic hydrogen in the laboratory using an innovative approach, and to study its metastability properties. Current theoretical and experimental considerations expect that extremely high pressures of order 4-6 megabar are required to transform molecular hydrogen to the metallic phase. When metallic hydrogen is produced in the laboratory it will be extremely important to determine if it is metastable at modest temperatures, i.e. remains metallic when the pressure is released. Then it could be used as the most powerful chemical rocket fuel that exists and revolutionize rocketry, allowing single-stage rockets to enter orbit and chemically fueled rockets to explore our solar system.

Metallic↗
NASA NTRS1993

Effects of low earth orbit

The effects of low earth orbit on the Long-Duration Exposure Facility (LDEF) spacecraft are reported. The LDEF spacecraft was deployed in low earth orbit in 1984 and was retrieved in 1990. The structure and design of LDEF is described. The dose of ionizing radiation received, data obtained, and its effects on the satellite are discussed. Atomic oxygen surface effects, oxygen induced damage, and damage from meteoroids and man-made debris are examined and an analysis of meteoroid impacts is presented. The effects of molecular and particulate contamination of the spacecraft's surface and instrument damage were analyzed. Post-flight analysis of LDEF's framework and experiments provided much information about the space environment and its effects on spacecraft materials and will be useful in the design of long-lived large space structures.

Murr, Lawrence E.↗
NASA NTRS2002

Far Ultraviolet Astronomy

The Far Ultraviolet Spectroscopic Explorer (FUSE) is studying a wide range of astronomical problems in the 905-1187 Angstrom wavelength region through the use of high resolution spectroscopy. The FUSE bandpass forms a nearly optimal complement to the spectral coverage provided by the Hubble Space Telescope (HST), which extends down to approximately 1170 Angstroms. The photoionization threshold of atomic hydrogen (911 Angstroms) sets a natural short-wavelength limit for the FUV. FUSE was launched in June 1999 from Cape Canaveral, Florida, on a Delta II rocket into a 768 km circular orbit. Scientific observations started later that year. This spectral region is extremely rich in spectral diagnostics of astrophysical gases over a wide range of temperatures (100 K to over 10 million K). Important strong spectral lines in this wavelength range include those of neutral hydrogen, deuterium, nitrogen, oxygen, and argon (H I, D I, N I, O I, and Ar I), molecular hydrogen (H2), five-times ionized oxygen (O VI), and several ionization states of sulfur (S III - S VI). These elements are essential for understanding the origin and evolution of the chemical elements, the formation of stars and our Solar System, and the structure of galaxies, including our Milky Way. FUSE is one of NASA's Explorer missions and a cooperative project of NASA and the space agencies of Canada and France. These missions are smaller, more scientifically focused missions than the larger observatories, like Hubble and Chandra. FUSE was designed, built and operated for NASA by the Department of Physics and Astronomy at Johns Hopkins University. Hundreds of astronomers world-wide are using FUSE for a wide range of scientific research. Some of the important scientific discoveries from the first two years of the mission are described.

Sonneborn, George↗
NASA NTRS2012

Frequency Correction for MIRO Chirp Transformation Spectroscopy Spectrum

This software processes the flyby spectra of the Chirp Transform Spectrometer (CTS) of the Microwave Instrument for Rosetta Orbiter (MIRO). The tool corrects the effect of Doppler shift and local-oscillator (LO) frequency shift during the flyby mode of MIRO operations. The frequency correction for CTS flyby spectra is performed and is integrated with multiple spectra into a high signal-to-noise averaged spectrum at the rest-frame RF frequency. This innovation also generates the 8 molecular line spectra by dividing continuous 4,096-channel CTS spectra. The 8 line spectra can then be readily used for scientific investigations. A spectral line that is at its rest frequency in the frame of the Earth or an asteroid will be observed with a time-varying Doppler shift as seen by MIRO. The frequency shift is toward the higher RF frequencies on approach, and toward lower RF frequencies on departure. The magnitude of the shift depends on the flyby velocity. The result of time-varying Doppler shift is that of an observed spectral line will be seen to move from channel to channel in the CTS spectrometer. The direction (higher or lower frequency) in the spectrometer depends on the spectral line frequency under consideration. In order to analyze the flyby spectra, two steps are required. First, individual spectra must be corrected for the Doppler shift so that individual spectra can be superimposed at the same rest frequency for integration purposes. Second, a correction needs to be applied to the CTS spectra to account for the LO frequency shifts that are applied to asteroid mode.

Lee, Seungwon↗
NASA NTRSDate not supplied

Improving Efficacy and Safety of Pharmacological Treatment Through Precision Health and Pharmacogenomics

INTRODUCTION: Future spaceflight will require increased crew medical autonomy as exploration class missions expand in duration and distance from Earth, especially for Mars missions. As mission duration increases, it will be essential to have appropriate amounts of effective medication to ensure the maintenance of crew health and performance. Conversely, mass and volume constraints will become more severe as future spaceflight expands beyond low Earth orbit, where resupply is difficult or becomes impossible. These constraints thus convey an urgency to tailor medications for individual crewmembers and further examine appropriate dosing regimens. BACKGROUND: Precision Health is an exciting area of medicine focused on maintaining an individual’s health and performance through in-depth understanding of an individual’s unique clinical and environmental history, genetic makeup, and molecular profiles. This approach can be adapted to better predict, monitor, and address physiological responses to the spaceflight environment. A subset of this field is pharmacogenomics (PGX), the study of how the expressed genome impacts drug responses with the goal of prescribing the right dose of the right drug at the right time. Specifically, PGX testing provides valuable information on an individual’s precise allelic variations to guide physicians in making informed decisions on drug choice and dosing to avoid adverse events and maximize efficacy. The study goal was to identify which current space pharmacy drugs could be evaluated using PGX testing and to understand the potential impact on the health and wellness of the astronaut population. Additionally, we sought to evaluate clinically available FDA-approved PGX testing solutions to better understand its applicability. METHODS: A complete list of drugs on the ISS was analyzed for risk and likelihood of drug failure and PGX actionability. This analysis encompassed both astronauts’ personal medications, including supplements and over the counter drugs (n=151) contained in the ISS medical accessory kit (IMAK), and ISS MedKit formulary medications (n=95). Duplicate medications and different formulations were removed, which resulted in a total of 157 drugs used in the subsequent analysis. A 5x5 risk assessment table was produced by examining the likelihood of drug failure compared to the consequence of drug failure (LxC). Likelihood of individual drug failure was defined by whether existing processes are sufficient to prevent ineffective treatment or impactful side effect events, as ranked from 1 (very low, can easily be prevented) to 5 (very high, cannot be prevented) during a Mars mission. In contrast, the consequence of drug failure was defined by impact to safety, schedule, cost, or technical criteria and ranked from 1 (very low) to 5 (very high). An assessment of PGX reference laboratories is currently underway to evaluate sample requirements, benefit analysis (cost vs. utility of allele variant analysis), relevance to inflight medication usage, quality of reporting in enabling clinical application, and ease of integration into electronic medical records. RESULTS: Risk assessments (LxC 5x5 table) indicated 128 medications were in the green zone where risk is acceptable, with the remaining 29 of the medications in the yellow or red zone driven predominantly due to drug failure or safety concerns. We found that current PGX testing results could impact 21% of the total medications in the ISS MedKit and IMAK; of these, 9 medications currently have direct clinically actionable guidance available. Results of the clinical PGX solution evaluations as related to these medications will be presented. CONCLUSION: PGX testing has demonstrated clear benefits in terrestrial medicine and clinical environments for the selection of proper medications, avoiding adverse drug reactions, and maximizing drug efficacy. We propose that similar benefits would be bestowed on the astronaut and commercial spaceflight passenger population by performing preemptive preflight PGX testing to reduce risk of mission failure due to ineffective or toxic medications, improve drug efficacy, and further open the door to countermeasure research. For example, PGX results could allow tailoring of specific medications at optimal doses more precisely to each individual astronaut, particularly in areas of space motion sickness, sleep aids, and analgesics. An additional benefit is that PGX results could provide information for better planning of the components of a space pharmacy for deep space missions to be more effective and efficient in the utilization of limited pharmaceutical resources. Finally, while PGX testing of the astronaut corps is not currently conducted, this approach could provide immediate impact in support of mission success by reducing risks, optimizing astronaut performance, and providing valuable insights into long-term astronaut health. Such advancements in clinical decision making are important next steps in building dynamic individual risk profiles for astronauts, increasing selection of the best treatment choice, and providing tailored countermeasures for individual crewmembers.

Pharmacogenomics↗
NASA NTRS1985

A measurement of the vibrational band strength for the upsilon sub 3 band of the HO2 radical

The HO2 radicals generated in a discharge-flow system were observed with tunable diode laser absorption in the P-branch of the nu(3) vibrationall band at 1080/cm. The observed line positions agree with those calculated from the molecular constants for the nu(3) bland obtained from a previous study using laser magnetic resonance spectroscopy. The band strength was determined by observing line center absoptions when HO2 is produced in the reaction F + H2O2 yields HO2 + HF (k1) with a measured concentration of atomic fluorine and excess hydrogen peroxide. F-atom concentrations are measured by diode laser absorption of the spin-orbit transition at 404/cm. The analysis accounts for HO2 losses due to the reactions of HO2 + HO2 yields H2O2 + O2 (k3) and F + HO2 yields HF + O2 (k4). The line strength for the 6(15) 7(16) F(1) transition is 2.9 x 10 to the 21st power sq cm/molecule/cm which corresponds to a nu(3) band strength of 34 +/- 9 sq/cm(STP atm). This value is a factor of 6 lower than previous ab initio calculations. These results will be useful in assessing the feasibility of atmospheric measurements of HO2 using infrared absorption techniques.

Zahniser, M. S.↗
NASA NTRS1992

Effects of LDEF flight exposure on selected polymer matrix resin composite materials

The characterization of selected graphite fiber reinforced epoxy (934 and 5208) and polysulfone (P1700) matrix resin composites materials which received over five years and nine months of exposure to the low earth orbit (LEO) environment in experiment AO134 on the Long Duration Exposure Facility is reported. The changes in mechanical properties of ultimate tensile strength and tensile modulus for exposed flight specimens are compared to the three sets of control specimens. Marked changes in surface appearance are discussed, and resin loss is reported. The chemical characterization including infrared, thermal, and selected solution property measurements showed that the molecular structure of the polymetric matrix had not changed significantly in response to this exposure.

Slemp, Wayne S.↗
NASA NTRSDate not supplied

Improving Efficacy and Safety of Pharmacological Treatment Through Precision Medicine and Pharmacogenomics for Human Deep Space Exploration

INTRODUCTION: Future spaceflight will require increased crew medical autonomy as exploration class missions expanding duration and distance from Earth, especially for Mars missions. As mission duration increases, it will be even more essential to have appropriate amounts of effective medication to ensure the maintenance of crew health and performance. Conversely, mass and volume constraints will become more severe as future spaceflight expands beyond low Earth orbit, where resupply is difficult or becomes impossible. These constraints thus convey an urgency to further tailor medications included in the spacecraft formulary and increased examination of appropriate dosing regimens. BACKGROUND: Precision Health is an exciting area of cutting-edge research and medicine focused on maintaining an individual’s health and performance through in-depth understanding of an individual’s unique factors and molecular profiles. This approach can be adapted to better predict, monitor, and address physiological responses to the spaceflight environment. One example is the field of pharmacogenomics (PGX),the study of how the expressed genome impacts drug responses with the goal of prescribing the right dose of the right drug at the right time. Specifically, PGX testing provides valuable information on an individual’s precise allelic variations to guide physicians in making informed decisions on pharmaceutical choice and dosing to avoid adverse drug events and maximize pharmacological efficacy. The goal of this study was to evaluate which drugs in the current space pharmacy could be evaluated using PGX testing and to understand the potential impact on the health and wellness of the astronaut population. Additionally, we sought to evaluate clinically available FDA-approved PGX testing solutions to better understand its applicability. METHODS: A complete list of drugs onboard the International Space Station (ISS) was analyzed for risk and likelihood of drug failure and PGX actionability. This analysis encompassed both personal astronaut medications, including supplements and over the counter drugs (n=151) and ISS MedKit formulary medications (n=95). Duplicate medications and different formulations were removed, which resulted in 157 total drugs used in the subsequent analysis. A 5x5 risk assessment table was produced by examining the likelihood of drug failure compared to the consequence of drug failure. Likelihood of individual drug failure was defined by whether existing processes are sufficient to prevent adverse events, as ranked from 1 (very low, can easily be prevented) to 5 (very high, cannot be prevented) during a Mars mission. In contrast, the consequence of drug failure was defined by impact to safety, schedule, cost or technical and ranked from 1 (very low) to 5 (very high).A comprehensive assessment of commercially available PGX solutions is currently underway to evaluate specimen requirements, cost/benefit analysis (cost vs. number of alleles assessed), utility of variant analysis, relevance to inflight medication usage, quality of reporting in enabling clinical application, and ease of integration into electronic medical records. RESULTS: Risk assessments(LxC 5x5 table) indicated29medicationswere in the yellow or red zone driven predominantly by drug failure or safety concerns, with the remainder(n=128)of the medications in the green zone where risk is acceptable. We found that current PGX testing results could impact 21% of the total medications in the ISS MedKit and IMAK; of these, 9 medications currently have direct clinically actionable guidance available. Results of the clinical PGX solution evaluations as related to these medications will be presented. CONCLUSION: PGX testing has demonstrated clear benefits in terrestrial medicine and clinical environments for the selection of proper medications, avoiding adverse drug reactions, and maximizing drug efficacy. We propose that similar benefits would be bestowed on the astronaut and commercial spaceflight passenger population by performing preemptive pre-flight PGX testing to reduce risk of mission failure due to ineffective or toxic medications, improve targeting drug efficacy and safety, and further open the door to countermeasure research exploring PGX-related allelic variants. For example, PGX results could allow tailoring of specific medications at optimal doses more precisely to each individual astronaut, particularly in areas of space motion sickness, sleep aids, and analgesics. An additional benefit is that PGX results could provide information for better planning of the components of a space pharmacy for deep space missions to be more cost effective and more efficient in the utilization of limited pharmaceutical resources. Finally, while PGX testing of the astronaut corps is not currently conducted, this approach could provide immediate impact in support of mission success by reducing risks, optimizing astronaut performance, and providing valuable insights into long-term astronaut health. Such advancements in clinical decision making are important next steps in building dynamic individual risk profiles for astronauts, increasing crew autonomy and providing tailored countermeasures

Alice R W Tang↗
NASA NTRS1982

Doppler line profiles measurement of the Jovian Lyman Alpha emission with OAO-C

Observation of Jupiter made with the high resolution ultraviolet spectrometer of the Orbiting Astronomical Observatory copernicus in April and May, 1980, yield a Jovian Lyman alpha emission intensity of 7 + or 2.5 RR. This indicates a decrease by about a factor of two since the Voyager ultraviolet spectrometer measurements, nearly a year earlier. An unusually high column abundance of hydrogen atoms above the methane homopause at the Voyager epoch is indicated. Since the auroral charged particle bombardment of molecular hydrogen is expected to contribute significantly to the global population of the hydrogen atoms, it is suggested that at the time of the Voyager Jupiter encounter unusually high auroral activity existed, perhaps d to the high concentration of the Io plasma torus. The temporal variation of the Saturn lyman alpha emission, when contrasted with the Jovian data, reveals that the auroral processes are not nearly as important in determining the Saturn Lyman alpha intensity in the nonauroral region.

Barker, E. S.↗
NASA NTRS1991

A space ultra-vacuum experiment - Application to material processing

An experiment to create and characterize an ultra-vacuum environment in low earth orbit is being developed. A wake region is known to form behind a satellite in low earth orbit. Limited theoretical and experimental results for flowfields around spacecraft are available and a brief discussion of these results is presented. The space experiment package to create an ultra-vacuum condition in the wake region is referred to as the Wake Shield Facility (WSF), manifested for flight on the Space Shuttle in 1993. In the vacuum region, epitaxial thin-films will be processed by molecular and chemical beam epitaxial growth techniques. Various particle flowfield and materials processing considerations for this experiment are presented.

Sega, R. M.↗
NASA NTRS1988

ESCA study of Kapton exposed to atomic oxygen in low earth orbit or downstream from a radio-frequency oxygen plasma

The ESCA spectra of Kapton polyimide film exposed to atomic oxygen O(3P), either in low earth orbit (LEO) on the STS-8 Space Shuttle or downstream from a radio-frequency oxygen plasma, were compared. The major difference in surface chemistry induced by the two types of exposure to O(3P), both of which caused surface recession (etching), was a much larger uptake of oxygen by Kapton etched in the O2 plasma than in LEO. This difference is attributed to the presence of molecular oxygen in the plasma reactor and its absence in LEO: in the former case, O2 can react with radicals generated in the Kapton molecule as it etches, become incorporated in the etched polymer, and thereby yield a higher steady-state 'surface oxidation' level than in LEO.

Golub, Morton A.↗